Vasoactive Intestinal Peptide Decreases β-Amyloid

“Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer’s Disease”¹

1.
Korkmaz OT, Ay H, Aytan N, et al. Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer’s Disease. J Mol Neurosci. Published online November 29, 2018:389-396. doi:10.1007/s12031-018-1226-8

Orhan Tansel Korkmaz PhD Vasoactive Intestinal Peptide
A medical researcher and a Member of Faculty at ESOGU Medical Faculty, Dept. of Physiology.
Orhan Tansel Korkmaz has a PhD from the Boston University School of Medicine. Orhan Tansel Korkmaz PhD currently works at the Eskisehir Osmangazi University and has 3 year experience in researching β-Amyloid Accumulation at the Eskisehir Osmangazi University. One of their notable works include "Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer’s Disease". Published online November 2018. doi:https://doi.org/10.1007/s12031-018-1226-8 [PubMed]
Research Gate | Google Scholar | LinkedIn